Eiger BioPharmaceuticals Inc (NASDAQ:EIGR)
| 10.34 Delayed Data As of Sep 18 |  -0.02 / -0.19%Today’s Change | 4.55 Today|||52-Week Range 15.82 | -30.60% Year-to-Date |
Latest EIGR News | Press Releases
| Implied Volatility Surging for Eiger BioPharmaceuticals (EIGR) Stock Options Sep 15 / Zacks.com - Paid Partner Content | Stocks To Watch: Spotlight On Palo Alto Networks, Best Buy And Xpeng Motors Aug 22 / Seeking Alpha - Paid Partner Content |
| Enanta Pharma reports encouraging data on HBV and NASH candidates Aug 28 / Seeking Alpha - Paid Partner Content | Seeking Alpha Catalyst Watch Aug 21 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 10.36 |
| Today’s open | 10.45 |
| Day’s range | 10.14 - 10.52 |
| Volume | 10,407 |
| Average volume (3 months) | 429,846 |
| Market cap | $293.6M |
Data as of 4:00pm ET, 09/18/2020
Growth & Valuation
| Earnings growth (last year) | +19.31% |
| Earnings growth (this year) | +71.24% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.36 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| UROVUrovant Sciences Ltd | +0.38 | +3.91% |
| VYNEVyne Therapeutics In... | +0.03 | +1.66% |
| AQSTAquestive Therapeuti... | +0.12 | +1.35% |
| PRTKParatek Pharmaceutic... | +0.15 | +2.30% |
Data as of 4:27pm ET, 09/18/2020
Financials
| Next reporting date | November 5, 2020 |
| EPS forecast (this quarter) | -$0.61 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$70.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Palo Alto, California |
Forecasts
